ArticleEuropean child & adolescent psychiatry2026
Network relationships between emotional dysregulation and ADHD symptoms: an investigation of 13,207 clinical children and adolescents.
Article in European child & adolescent psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical Characteristics of Adolescents Admitted to a Child and Adolescent Psychiatry Department in Poland: A Retrospective Chart Review.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
This study employed network analysis to examine the co-occurrence patterns of emotional dysregulation (ED) and attention-deficit/hyperactivity disorder (ADHD) symptoms in clinically referred children and adolescents. A total of 13,207 children and adolescents meeting the research criteria were included in the analysis. ED was assessed using the Strengths and Difficulties Questionnaire-dysregulation profile (SDQ-DP), while ADHD symptoms were evaluated using The Swanson, Nolan, and Pelham Rating Scale-IV, parent-report version (SNAP-IV). The study examined central and bridging symptoms within the network model. The research identified that the node SNAP-2 ("Often has difficulty sustaining attention in tasks or play activities") is the most central symptom in the ED-ADHD co-occurrence network model. Nodes SDQ-2 ("Restless, overactive, cannot stay still for long"), SDQ-13 ("Often unhappy, depressed or tearful"), and SDQ-5 ("Often loses temper") emerged as core symptoms within the ED community, indicating that excitability, depression, and irritability are common subtypes of emotional dysregulation in the co-occurrence model. Bridging symptoms include node SDQ-2 ("Restless, overactive, cannot stay still for long"), node SDQ-15 ("Easily distracted, concentration wanders"), and node SNAP-14 ("Often is 'on the go' or acts as if 'driven by a motor'"), linking hyperactive/impulsive symptoms and attention deficits with co-occurring emotional dysregulation. The core and bridging symptoms identified in this study may serve as targets for prevention and treatment of co-occurring ED and ADHD in clinical children and adolescents. The most common subtypes of emotional dysregulation symptoms co-occurring with ADHD represent targets for personalized treatment.
Indexed as
Identifiers
40705055What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.